, its metabolite docosapentaenoic acid (DPA, 22:5) and docosahexaenoic acid (DHA, 22:6) are the major n-3 PUFAs derived primarily from dietary consumption. Whether their effects on health are shared or complementary is a matter of current debate. To understand how molecular organization within cell membranes responds to the incorporation of each n-3 PUFA into phospholipids, we are performing MD simulations on model membrane systems composed of 1-stearoyl-2-eicosapentaenoylphosphatidylcholine (18:0-20:5PC), 1-stearoyl-2-docosapentaenoylphosphatidylcholine (18: 0-22:5PC), 1-stearoyl-2-docoshexaenoylphosphatidylcholine (18:0-22:6PC) and, as a monounsaturated comparison, 1-stearoyl-2-oleoylphosphatidylcholine (SOPC, 18:0-18:1PC) in the absence and presence of cholesterol. They are run at 37 C under constant pressure for 200 ns on bilayers containing 98 lipid molecules (single component membranes) or 100 lipid molecules (80 phospholipids and 20 cholesterols) that are hydrated in the ratio of 20 water molecules per lipid molecule. As validation, order parameter profiles along the sn-1 chain calculated from the trajectories will be compared with results from solid state 2H NMR experiments. Our analysis will identify the difference in flexibility between EPA, DPA and DHA chains. The impact of the difference in flexibility of each n-3 PUFA on the conformation of the adjacent stearic acid chain at the sn-1 position and on the interaction with cholesterol will then be investigated.
Department of Biochemistry & Molecular Biology and East Carolina
Diabetes and Obesity Institute, East Carolina University, Greenville, NC, USA. Dietary omega-3 polyunsaturated fatty acids (n-3 PUFAs), such as docosahexaenoic acid (DHA, 22:6) , have a wide variety of health benefits. However, the origin of the benefits at the molecular level is yet to be elucidated. A membrane-mediated mechanism in which n-3 PUFAs are incorporated into phospholipids and modulate molecular organization is one possibility. Cellular membranes are inhomogeneous where structurally diverse lipids can exist in separate domains. Regions rich in sphingomyelin (SM) and cholesterol, commonly called lipid rafts, contain important signaling proteins. In a recent solid-state 2 H nuclear magnetic resonance ( 2 H NMR) study of a model membrane composed of 1-[ 2 H 31 ] palmitoyl-2-docosahexaenoylphosphatidylcholine (PDPC-d 31 ), a deuterated analog of a DHA-containing phospholipid, in mixtures with SM and cholesterol, we discovered that DHA could significantly enter raft-like domains. How DHA affects the molecular organization within the raft-like domains is addressed here by observing PSM-d 31 , an analog of SM with a perdeuterated N-palmitoyl chain. The 2 H NMR spectra for PSM-d 31 in mixtures with PDPC and cholesterol exhibit two spectral components, a larger more ordered component that we attribute to raft-like domains and a smaller less ordered component that we attribute to non-raft-like domains. On average, the order of PSM-d 31 is reduced and, thus, disordering of PSM-d 31 by PDPC is indicated. Our observations confirm that DHA can infiltrate rafts and affect molecular organization, which has implications for the signaling of raft and non-raft proteins. Furthermore, these results are consistent with in vivo studies showing that DHA infiltrates rafts.
Oak Ridge National Laboratory, Oak Ridge, TN, USA, 6 Department of Physics, University of Tennessee, Knoxville, TN, USA. Polyunsaturated fatty acids (PUFA) are found in great abundance in neural membranes where they are essential for function. Their incorporation into membrane phospholipids has also been proposed to be responsible, in part, for a plethora of health benefits associated with dietary consumption of fish oils. Extremely high disorder that deters close proximity to cholesterol is what distinguishes PUFA from more common monounsaturated and saturated fatty acids. The aversion to cholesterol is exemplified by a solubility of only~15 mol% in di-polyunsaturated 1,2-diarachidonylphosphatidylcholine (DAPC), as opposed to most phospholipid bilayers that can solubilize >50 mol%. According to our earlier neutron scattering experiments using deuterated analogs of cholesterol, the head group and tail of the sterol reside within the DAPC bilayer at the center. An orientation parallel to the plane of the bilayer and between leaflets is implied that, remarkably, differs from the generally accepted one in which the head group sits near the aqueous interface while the tail extends towards the middle of the bilayer. Here we present solid state 2 H NMR spectra acquired with aligned multilayers that establish the bilayer normal constitutes the axis of motional averaging for a deuterated analog of cholesterol incorporated into DAPC. The dilemma that this result creates is being evaluated, including with the aid of molecular dynamics simulations. Vitamin E (a-tocopherol) is a lipid-soluble antioxidant that has the role of protecting phospholipids from oxidation in membranes. A question that remains is how the low concentration of a-tocopherol found in whole cells can protect the relatively large concentration of polyunsaturated phospholipids found in membranes that are particularly vulnerable to oxidative attack. We hypothesize that a-tocopherol co-localizes with polyunsaturated phospholipids to optimize its role as an antioxidant. This project attempts to test this hypothesis by comparing the effect of a-tocopherol on the molecular organization of 1-palmitoyl-2-docosahexaenoyl-sn-glycerophosphatidylethanolamine (16:0-22:6PE, PDPE) and, as a monounsaturated control, 1-palmitoyl-2-oleoylsn-glycerophosphatidylethanolamine (16:0-18:1PE, POPE) in mixtures with sphingomyelin (SM). By solid-state 2 H NMR spectroscopy, we directly observe order and phase behavior of POPE-d 31 and PDPE-d 31 (analogs of POPE and PDPE with a perdeuterated sn-1 chain) in the mixed membranes. In complementary X-ray diffraction and differential scanning calorimetry experiments we further probe phase behavior. The spectra observed for POPEd 31 in POPE/SM/a-tocopherol (2:2:1 mol) reveal that a transition from gel to liquid crystalline phase is no longer apparent. At higher temperatures there is a superposition of two spectral components that we ascribe to a-tocopherol promoting a transition from lamellar to inverted hexagonal (H II ) phase. Analysis of depaked spectra shows that order is increased by about 8 % and that the amount of H II phase increases with temperature, ranging from 7 (31 C) to 41 % (65 C). In mixed membranes where POPE-d 31 is replaced by PDPE-d 31 , we shall investigate whether there is a greater tendency for a-tocopherol to increase order and destabilize bilayer structure for the polyunsaturated phospholipid.
2076-Pos
2077-Pos Board B214 Molecular Dynamics Studies of Lipid I and Lipid II in Various of Lipid Bilayer Environments Seonghoon Kim, Wonpil Im. The University of Kansas, Lawrence, KS, USA. The peptidoglycan biosynthesis and assembly is needed for (both gramnegative and positive) bacterial cell wall formation. In the pathway, there are lipid-linked precursors such as lipid I (in the inner leaflet of the cytoplasmic membrane) and lipid II (in its outer leaflet). In addition, by peptidoglycan glycosyltransferase, one peptidoglycan unit from lipid II is transferred to the growing peptidoglycan oligomers attached to lipid II (lipid II-PG(x); x is the number of transferred peptidoglycan units). In this work, lipid I, lipid II-PG(0), lipid II-PG(2), lipid II-PG(5) of both gram-negative and positive bacteria are modeled and simulated in all-atom POPE/POPG (3:1; gram-negative membrane mimetics), POPE/POPG (1:3; gram-positive membrane mimetics), and POPC (neutral) bilayers. Presented and discussed are the structure and dynamics of the lipid-linked precursors and their dependence on bilayer types and vice versa. The preferred structures of these precursors are also discussed in terms of the reactions in (1) glycosyltransferase to add GlcNAc to lipid I, (2) peptidoglycan glycosyltransferase to add peptidoglycan units to lipid II-PG(x), and (3) transpeptidase that cross-links the peptidoglycan units.
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